Coming live on September 11

Microbiome Symposium 2017
Monday September 11, 8:00AM - 7:00PM

Now in its second year, the purpose of the conference is to bring together leading minds looking to catalog the human microbiome using modern genetics tools and especially those looking to apply new computational technologies to solve complicated problems in metagenomics to answer such questions such as:

  • How are changes in the microbiome associated with diseases in the population,
  • How can you identify novel microbes using sequence-based analysis,
  • How can you improve patient outcomes by characterizing microbiome dynamics,
  • How can you better understand host-microbiome symbiosis to be able to understand and target microbial vulnerabilities,
  • How can you track dynamic microbiome shifts during disease, etc.


While genetics tools to characterize the human microbiome is no doubt important, the goal of this conference is to focus on computational tools that help solve any or all of the above complicated metagenomics problems.


Loading Map...

Quadrus Conference Center

2400 Sand Hill Rd
Menlo Park CA, 94025
Get Directions

From San Francisco
Take 280 south to the Sand Hill Road exit. Go east on Sand Hill Road for 1.5 miles, then turn left at the light at Saga Way.

From San Jose
Go Take 280 north to the Sand Hill Road exit. Go east on Sand Hill Road for 1.5 miles, then turn left at the light at Saga Way.


Free parking is available at Quadrus Conference Center.

Quadrus parking info

Quadrus website

Event Organizers

Ami Bhatt, Assistant Professor, Departments of Medicine and Genetics, Divisions of Hematology and Blood and Marrow Transplantation, Stanford University

Ami is an Assistant Professor of Medicine and Genetics at Stanford University School of Medicine. She earned an M.D. and Ph.D. (Biochemistry and Molecular Biology) at the University of California, San Francisco and did her post-graduate training at Brigham and Women's Hospital, Dana-Farber Cancer Institute and the Broad Institute.

The Bhatt laboratory ( investigates relationships between the human microbiome and noncommunicable diseases, including cancer. Specifically, they focus on (1) the use of next generation sequencing to define the microbiome and host immunologic features in patients with human diseases and (2) developing molecular and ccomputational tools for the identification of novel organisms and strain variation in these inpatient populations, and (3) using statistical and functional biological methods to understand the complex interplay between the human microbiome and host biology.

Ami enjoys creative applications of genetics and computational biology in the field of microbiome research and is the winner of the 2016 Damon Runyon Clinical Investigator Award. In her spare time, she co-founded a nonprofit (Global Oncology) and she directs the Global Oncology Program for the Stanford Center for Innovation in Global Health.  

Ramesh Nair, PhD, Acting Director, Bioinformatics, Stanford Center for Genomics and Personalized Medicine, Stanford University

As Acting Director, Bioinformatics at Stanford Center for Genomics and Personalized Medicine (SCGPM), Ramesh is the bioinformatician in residence for the California Institute of Regenerative Medicine (CIRM) initiated Stem Cell Center of Excellence (CESCG). He is responsible for diverse bioinformatics needs for the Center Initiated Projects and its extensive collaboration network. He brings a diverse engineering and extensive scientific background to solve some of the biggest technical challenges in biotechnology.

Prior to joining SCGPM, Ramesh was a Bioinformatics Analyst at Center for Cancer Systems Biology (CCSB) where among other things, he was sole developer of next-generation sequencing (NGS) pipelines for genome sequencing (Exome-Seq) applied to follicular lymphoma and transcriptome sequencing (RNA-Seq) applied to lung cancer tumor microenvironment. Prior to joining Stanford, he was a Sr. Scientist at various Biotech firms in Bay Area including Cobalt Biofuels, Iconix BioSciences (now Entelos), Lynx Therapeutics (now Illumina) and DuPont. Ramesh has a PhD in Chemical Engineering from Northwestern University and MTech in Biochemical Engineering and Biotechnology from Indian Institute of Technology Delhi.